Browse Category

LSE:GSK News 21 January 2026

RAPT Therapeutics stock jumps 64% as GSK agrees $2.2 billion takeover at $58 a share

RAPT Therapeutics stock jumps 64% as GSK agrees $2.2 billion takeover at $58 a share

NEW YORK, Jan 20, 2026, 18:51 EST — After-hours Rapt Therapeutics (NASDAQ: RAPT) surged roughly 64% to $57.57 in after-hours trading Tuesday following news that Britain’s GSK will acquire the U.S. biotech. GSK’s $58-a-share cash bid values the deal at about a 65% premium over Monday’s close. This is the first big move by CEO Luke Miels, who just took…

Stock Market Today

  • DXBG Stock Analysis: Neutral Ratings and Trading Signals for January 21, 2026
    January 21, 2026, 9:42 AM EST. Dynamic Global Fixed Income Fund (DXBG:CA) holds neutral ratings across near, mid, and long-term perspectives as of January 21, 2026. Updated AI-generated trading signals suggest a buy near 19.99 CAD, targeting 20.06, with a stop loss at 19.89. Alternatively, short positions are recommended near 20.06, targeting 19.99, with a stop loss at 20.16. These signals guide traders in managing risk and optimizing entry and exit points amid market movements.
Go toTop